Intraoperative 20% albumin administration was not associated with increased AKI risk or 30-day mortality after adjusting for confounders in patients undergoing major abdominal surgery with RBC transfusion, although it was related to prolonged hospitalization. The gene discussed is ALB; the disease is acute kidney injury.